Adrienne M. Hammill - Concepedia

Author

Adrienne M. Hammill

Cincinnati Children's Hospital Medical Center ORCID

Also Known As

A. Hammill, A. K. Hammill, A. M. Hammill, A.M. Hammill, Adrienne Hammill, Adrienne K. Hammill, Adrienne M Hammill, Adrienne M. Hammill, Adrienne M. Hammilll, Adrienne Marie Hammill

Publications

4.1K

Citations

H-Index

Concepts

All Affiliations

Cincinnati Children's Hospital Medical Center University of Cincinnati Medical Center University of Cincinnati Boston Children's Hospital Harvard University

About

Adrienne M. Hammill is an author at Cincinnati Children's Hospital Medical Center specializing in medicine, neurology, and pediatrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	18	1K
2	Education	2	2	39
3	Engineering	1	2	44
4	Health Sciences	1	1	29
5	Public Health	1	1	13

Adrienne M. Hammill

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies Denise M. Adams, Cameron C. Trenor, Adrienne M. Hammill, PEDIATRICS	2016	785
Sirolimus for the treatment of complicated vascular anomalies in children Adrienne M. Hammill, MarySue Wentzel, Anita Gupta, Pediatric Blood & Cancer	2011	600
Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia Marie E. Faughnan, Johannes J. Mager, Steven W. Hetts, Annals of Internal Medicine	2020	467
Consensus-Derived Practice Standards Plan for Complicated Kaposiform Hemangioendothelioma Beth A. Drolet, Cameron C. Trenor, Leonardo R. Brandão, The Journal of Pediatrics HematologyVascular MalformationVascular SurgeryComplicated Kaposiform HemangioendotheliomaSurgery	2013	276
Annexin V Staining Due to Loss of Membrane Asymmetry Can Be Reversible and Precede Commitment to Apoptotic Death Adrienne M. Hammill, Jonathan W. Uhr, Richard H. Scheuermann Experimental Cell Research Membrane AsymmetryCell SignalingApoptosisHistopathologyAnnexin V	1999	194
Guidance Document for Hepatic Hemangioma (Infantile and Congenital) Evaluation and Monitoring Ionela Iacobas, Thuy L. Phung, Denise M. Adams, The Journal of Pediatrics Guidance DocumentHepatologyPediatricsVascular MalformationHepatic Hemangioma	2018	135
Efficacy of systemic sirolimus in the treatment of generalized lymphatic anomaly and Gorham–Stout disease Kiersten Ricci, Adrienne M. Hammill, Paula S. Mobberley‐Schuman, Pediatric Blood & Cancer	2019	114
Developmental pharmacokinetics of sirolimus: Implications for precision dosing in neonates and infants with complicated vascular anomalies Tomoyuki Mizuno, Tsuyoshi Fukuda, Chie Emoto, Pediatric Blood & Cancer	2017	81
Response of Blue Rubber Bleb Nevus Syndrome to Sirolimus Treatment Ralph Salloum, Courtney E. Fox, Carlos R. Alvarez‐Allende, Pediatric Blood & Cancer	2016	79
Malignant transformation of infantile hemangioma to angiosarcoma: Response to chemotherapy with bevacizumab Michael Jeng, Beng Fuh, Julie Blatt, Pediatric Blood & Cancer AngiogenesisMedicineBenign Vascular LesionMalignant TransformationMulti-focal Infantile Hemangioma	2014	63

Page 1